Selecting Your Drug Database

In this article, we will explore the advantages of drug databases, their use cases, the challenges of building and integ…

Telehealth has simplified and smoothed over healthcare pathways

In this interview, Marie-Laure Saillard, CEO of MesDocteurs, and Dr. Clément Goehrs, co-founder and CEO of Synapse Medic…

Retrospective: A Look Back at Synapse Medicine's 2020 Highlights Reel

Several Synapse Medicine employees contributed to this article, which will revisit many of the great projects the compan…

The Medication Shield explained by Dr. Clement Goehrs, co-founder and CEO of Synapse Medicine

The Medication Shield technology, which was developed thanks to a partnership between public and private sector, provide…

Synapse Medicine raises 8 million dollars to prevent drug-related risks everywhere in the world

July 6, 2020 – Synapse Medicine has announced that it has raised 8 million dollars, spearheaded by the MACSF, a leading …

A look inside the Coverage clinical trial by pharmacy extern Julie Perrot

As a pharmacy extern, I have been fortunate enough to work on the COVERAGE clinical trial promoted by Bordeaux Universit…

The current state of telemedicine in France

Telemedicine is broadly perceived as a solution that facilitates patient care. Today more than ever, people are looking …

How we help healthcare professionals and the general public during the Covid-19 pandemic

Since the beginning of the Covid-19 health crisis, our teams at Synapse Medicine have been hard at work developing techn…

How we built a COVID-19 platform that has helped 700,000 people and counting ー all in just 72 hours

At exactly 11:38 a.m. on Saturday 14 March, French Health Minister Olivier Véran tweeted the following message: “#COVID-…